AI reads allergy patches: could home testing get easier?
NCT ID NCT06387472
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested an artificial intelligence (AI) program called DermAI to see if it could accurately interpret photos of skin patch tests for contact dermatitis. Researchers compared the AI's readings to those of human experts. The goal was to make remote allergy testing more practical and reliable for people to use at home.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI algorithm (DermAI) and allergen patch
- What this could lead to
- If successful, this could make allergy patch testing more reliable and convenient for people to do from home.
- What could go wrong
- This was a small, completed study focused on comparing AI to human review. It does not test treatment or long-term outcomes, so results may not change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTACT DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.